# United Bankshares Inc: financial statements, quarterly

UBSI · Nasdaq · CIK 729986 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ubsi.md) · [Financials](/companies/ubsi/financials.md) · [Filings](/companies/ubsi/filings.md) · [Insiders](/companies/ubsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ubsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [128](/filings/0001193125-25-042589.md) | [139](/filings/0001193125-25-042589.md) | [147](/filings/0001193125-26-081470.md) | [148](/filings/0001193125-26-081470.md) | [152](/filings/0001193125-26-081470.md) | [143](/filings/0001193125-26-081470.md) | [144](/filings/0001193125-26-081470.md) | [147](/filings/0001193125-26-081470.md) | [151](/filings/0001193125-26-081470.md) | [143](/filings/0001193125-26-081470.md) | not reported | not reported |
| Income tax | $m | [24.8](/filings/0001193125-25-042589.md) | [24.8](/filings/0001193125-25-042589.md) | [21.4](/filings/0001193125-26-081470.md) | [18.9](/filings/0001193125-26-081470.md) | [24.6](/filings/0001193125-26-081470.md) | [26.7](/filings/0001193125-26-081470.md) | [22.6](/filings/0001193125-26-213783.md) | [31.4](/filings/0001193125-26-339565.md) | [33.7](/filings/0001193125-26-081470.md) | [31.1](/filings/0001193125-26-081470.md) | [31.8](/filings/0001193125-26-213783.md) | [32.8](/filings/0001193125-26-339565.md) |
| Net income | $m | [96.2](/filings/0001193125-25-042589.md) | [79.4](/filings/0001193125-25-042589.md) | [86.8](/filings/0001193125-26-081470.md) | [96.5](/filings/0001193125-26-081470.md) | [95.3](/filings/0001193125-26-081470.md) | [94.4](/filings/0001193125-26-081470.md) | [84.3](/filings/0001193125-26-339565.md) | [121](/filings/0001193125-26-339565.md) | [131](/filings/0001193125-26-081470.md) | [129](/filings/0001193125-26-081470.md) | [124](/filings/0001193125-26-339565.md) | [131](/filings/0001193125-26-339565.md) |
| Diluted EPS | $ per share | [0.71](/filings/0001193125-25-042589.md) | [0.59](/filings/0001193125-25-042589.md) | [0.64](/filings/0001193125-26-081470.md) | [0.71](/filings/0001193125-26-081470.md) | [0.70](/filings/0001193125-26-081470.md) | [0.69](/filings/0001193125-26-081470.md) | [0.59](/filings/0001193125-26-213783.md) | [0.85](/filings/0001193125-26-339565.md) | [0.92](/filings/0001193125-26-081470.md) | [0.91](/filings/0001193125-26-081470.md) | [0.89](/filings/0001193125-26-213783.md) | [0.95](/filings/0001193125-26-339565.md) |
| Basic EPS | $ per share | [0.71](/filings/0001193125-25-042589.md) | [0.59](/filings/0001193125-25-042589.md) | [0.64](/filings/0001193125-26-081470.md) | [0.71](/filings/0001193125-26-081470.md) | [0.70](/filings/0001193125-26-081470.md) | [0.70](/filings/0001193125-26-081470.md) | [0.59](/filings/0001193125-26-213783.md) | [0.85](/filings/0001193125-26-339565.md) | [0.92](/filings/0001193125-26-081470.md) | [0.92](/filings/0001193125-26-081470.md) | [0.89](/filings/0001193125-26-213783.md) | [0.95](/filings/0001193125-26-339565.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [29.2](/filings/0001193125-23-274243.md) | [29.9](/filings/0001193125-25-042589.md) | [30.0](/filings/0001193125-24-135768.md) | [30.0](/filings/0001193125-24-197630.md) | [29.9](/filings/0001193125-24-253904.md) | [30.0](/filings/0001193125-26-081470.md) | [32.8](/filings/0001193125-25-116615.md) | [32.8](/filings/0001193125-25-176529.md) | [33.4](/filings/0001193125-25-271463.md) | [33.7](/filings/0001193125-26-339565.md) | [33.7](/filings/0001193125-26-213783.md) | [33.8](/filings/0001193125-26-339565.md) |
| Total liabilities | $bn | [24.6](/filings/0001193125-23-274243.md) | [25.2](/filings/0001193125-25-042589.md) | [25.2](/filings/0001193125-24-135768.md) | [25.1](/filings/0001193125-24-197630.md) | [24.9](/filings/0001193125-24-253904.md) | [25.0](/filings/0001193125-26-081470.md) | [27.5](/filings/0001193125-25-116615.md) | [27.4](/filings/0001193125-25-176529.md) | [28.0](/filings/0001193125-25-271463.md) | [28.2](/filings/0001193125-26-339565.md) | [28.2](/filings/0001193125-26-213783.md) | [28.2](/filings/0001193125-26-339565.md) |
| Long-term debt | $bn | [1.1](/filings/0001193125-23-274243.md) | [1.8](/filings/0001193125-24-053462.md) | [1.5](/filings/0001193125-24-135768.md) | [1.2](/filings/0001193125-24-197630.md) | [0.3](/filings/0001193125-24-253904.md) | [0.5](/filings/0001193125-25-042589.md) | [0.3](/filings/0001193125-25-116615.md) | [0.3](/filings/0001193125-25-176529.md) | [0.3](/filings/0001193125-25-271463.md) | [0.5](/filings/0001193125-26-081470.md) | not reported | not reported |
| Short-term borrowings | $bn | [0.2](/filings/0001193125-23-274243.md) | [0.2](/filings/0001193125-25-042589.md) | [0.2](/filings/0001193125-24-135768.md) | [0.2](/filings/0001193125-24-197630.md) | [0.2](/filings/0001193125-24-253904.md) | [0.2](/filings/0001193125-26-081470.md) | [0.2](/filings/0001193125-25-116615.md) | [0.2](/filings/0001193125-25-176529.md) | [0.2](/filings/0001193125-25-271463.md) | [0.2](/filings/0001193125-26-339565.md) | [0.2](/filings/0001193125-26-213783.md) | [0.2](/filings/0001193125-26-339565.md) |
| Shareholders' equity | $bn | [4.6](/filings/0001193125-24-253904.md) | [4.8](/filings/0001193125-26-081470.md) | [4.8](/filings/0001193125-25-271463.md) | [4.9](/filings/0001193125-25-271463.md) | [5.0](/filings/0001193125-25-271463.md) | [5.0](/filings/0001193125-26-339565.md) | [5.3](/filings/0001193125-26-339565.md) | [5.4](/filings/0001193125-26-339565.md) | [5.4](/filings/0001193125-25-271463.md) | [5.5](/filings/0001193125-26-339565.md) | [5.5](/filings/0001193125-26-339565.md) | [5.5](/filings/0001193125-26-339565.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [89.6 d](/filings/0001193125-24-253904.md) | [163 d](/filings/0001193125-26-081470.md) | [124](/filings/0001193125-25-116615.md) | [61.2 d](/filings/0001193125-25-176529.md) | [124 d](/filings/0001193125-25-271463.md) | [136 d](/filings/0001193125-26-081470.md) | [120](/filings/0001193125-26-213783.md) | [89.4 d](/filings/0001193125-26-339565.md) | [151 d](/filings/0001193125-25-271463.md) | [139 d](/filings/0001193125-26-081470.md) | [161](/filings/0001193125-26-213783.md) | [105 d](/filings/0001193125-26-339565.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001193125-24-253904.md) | [3.2 d](/filings/0001193125-26-081470.md) | [4.8](/filings/0001193125-25-116615.md) | [3.0 d](/filings/0001193125-25-176529.md) | [1.6 d](/filings/0001193125-25-271463.md) | [2.8 d](/filings/0001193125-26-081470.md) | [3.9](/filings/0001193125-26-213783.md) | [4.2 d](/filings/0001193125-26-339565.md) | [4.2 d](/filings/0001193125-25-271463.md) | [5.4 d](/filings/0001193125-26-081470.md) | [4.8](/filings/0001193125-26-213783.md) | [7.2 d](/filings/0001193125-26-339565.md) |
| Dividends paid | $m | [48.7 d](/filings/0001193125-24-253904.md) | [48.7 d](/filings/0001193125-26-081470.md) | [50.1](/filings/0001193125-25-116615.md) | [50.2 d](/filings/0001193125-25-176529.md) | [50.2 d](/filings/0001193125-25-271463.md) | [50.2 d](/filings/0001193125-26-081470.md) | [50.5](/filings/0001193125-26-213783.md) | [53.3 d](/filings/0001193125-26-339565.md) | [52.7 d](/filings/0001193125-25-271463.md) | [52.5 d](/filings/0001193125-26-081470.md) | [53.4](/filings/0001193125-26-213783.md) | [53.3 d](/filings/0001193125-26-339565.md) |
| Share repurchases | $m | [0.0 d](/filings/0001193125-24-253904.md) | [0.0 d](/filings/0001193125-26-081470.md) | [1.0](/filings/0001193125-25-116615.md) | [0.0 d](/filings/0001193125-25-176529.md) | [0.0 d](/filings/0001193125-25-271463.md) | [0.0 d](/filings/0001193125-26-081470.md) | [20.3](/filings/0001193125-26-213783.md) | [32.6 d](/filings/0001193125-26-339565.md) | [26.5 d](/filings/0001193125-25-271463.md) | [47.6 d](/filings/0001193125-26-081470.md) | [70.3](/filings/0001193125-26-213783.md) | [66.0 d](/filings/0001193125-26-339565.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001193125-25-042589.md) | [0.1](/filings/0001193125-25-042589.md) | [135](/filings/0001193125-26-081470.md) | [135](/filings/0001193125-26-081470.md) | [136](/filings/0001193125-26-081470.md) | [136](/filings/0001193125-26-081470.md) | [143](/filings/0001193125-26-213783.md) | [142](/filings/0001193125-26-339565.md) | [142](/filings/0001193125-26-081470.md) | [141](/filings/0001193125-26-081470.md) | [140](/filings/0001193125-26-213783.md) | [138](/filings/0001193125-26-339565.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,212,571 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339565.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.